These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31612766)

  • 1. Association between benign prostate hyperplasia and metabolic syndrome in men under 60 years old: a meta-analysis.
    Wu S; He H; Wang Y; Xu R; Zhu B; Zhao X
    J Int Med Res; 2019 Nov; 47(11):5389-5399. PubMed ID: 31612766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients.
    Zou C; Gong D; Fang N; Fan Y
    World J Urol; 2016 Feb; 34(2):281-9. PubMed ID: 26119349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome components and prostatic hyperplasia among diabetic and non-diabetic men in the Eastern DR Congo: A cross-sectional study.
    Mubenga LE; Gruson D; Hermans MP; Bwenge E; Tombal B
    Diabetes Metab Syndr; 2019; 13(1):776-780. PubMed ID: 30641805
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
    Hammarsten J; Högstedt B
    Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
    Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
    Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and proliferation of the prostate cells in men with benign prostatic hyperplasia and concomitant metabolic disorders.
    Rył A; Rotter I; Kram A; Teresiński L; Słojewski M; Dołęgowska B; Lubkowska A; Piasecka M; Laszczyńska M
    Histol Histopathol; 2018 Apr; 33(4):389-397. PubMed ID: 28948599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.
    Xu C; Xu Y; Shen Z; Zhou H; Xiao J; Huang T
    Int Urol Nephrol; 2018 Apr; 50(4):611-617. PubMed ID: 29460133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and voiding dysfunction.
    Al Hussein Alawamlh O; Al Hussein Al Awamlh B; Lee RK
    Curr Opin Urol; 2017 Sep; 27(5):403-408. PubMed ID: 28604411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
    Park SG; Yeo JK; Cho DY; Park MG
    Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship between Eicosanoid Levels and Serum Levels of Metabolic and Hormonal Parameters Depending on the Presence of Metabolic Syndrome in Patients with Benign Prostatic Hyperplasia.
    Grzesiak K; Rył A; Stachowska E; Słojewski M; Rotter I; Ratajczak W; Sipak O; Piasecka M; Dołęgowska B; Laszczyńska M
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897712
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Association of Metabolic Syndrome and Benign Prostatic Hyperplasia in Chinese Patients of Different Age Decades.
    Kaplan SA
    J Urol; 2015 Oct; 194(4):1055-6. PubMed ID: 26382806
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
    Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.
    Kaplan SA
    J Urol; 2014 May; 191(5):1345-6. PubMed ID: 24745511
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
    Parsons JK; Sarma AV; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S27-31. PubMed ID: 19846130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of obesity in the pathogenesis of benign prostatic hyperplasia].
    Bratchikov OI; Tyuzikov IA; Artishchev SO; Shumakova EA
    Urologiia; 2020 Apr; (2):101-106. PubMed ID: 32351071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
    Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
    Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome is predictive of lower urinary tract symptom improvement after holmium laser enucleation of the prostate for benign prostatic obstruction.
    Kwon T; Park S; Park S; Moon KH
    Int Urol Nephrol; 2017 Jul; 49(7):1105-1110. PubMed ID: 28361474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.